当前位置:首页 >财报库 > 报告详情

西维斯健康CVS Health(CVS)2025年第二季财报电话会议纪要「NYSE」(英文版)(21页).pdf

上传人: 1****1 编号:870617 2025-08-27 21页 370.57KB

下载:

1、 Formatted Report 1-877-FACTSET Total Pages:21 Copyright 2001-2025 FactSet CallStreet,LLC 31-Jul-2025 CVS Health Corp.(CVS)Q2 2025 Earnings Call CVS Health Corp.(CVS)Q2 2025 Earnings Call Formatted Report 31-Jul-2025 1-877-FACTSET 2 Copyright 2001-2025 FactSet CallStreet,LLC CORPORATE PARTICIPANTS L

2、aurence F.McGrath Executive Vice President,Chief Strategy Officer and Chief Strategic Advisor to the CEO J.David Joyner President,Chief Executive Officer&Director Brian O.Newman Executive Vice President&Chief Financial Officer Steven H.Nelson Executive Vice President and President,Aetna Prem S.Shah

3、Group President&Executive Vice President .OTHER PARTICIPANTS Lisa C.Gill JPMorgan Securities LLC Justin Lake Wolfe Research LLC Stephen Baxter Wells Fargo Securities LLC George Hill Deutsche Bank Securities,Inc.Elizabeth Anderson Evercore ISI Andrew Mok Barclays Capital,Inc.Eric Percher Nephron Rese

4、arch LLC Erin Wilson Wright Morgan Stanley&Co.LLC John W.Ransom Raymond James&Associates,Inc.CVS Health Corp.(CVS)Q2 2025 Earnings Call Formatted Report 31-Jul-2025 1-877-FACTSET 3 Copyright 2001-2025 FactSet CallStreet,LLC MANAGEMENT DISCUSSION SECTION Laurence F.McGrath Executive Vice President,Ch

5、ief Strategy Officer and Chief Strategic Advisor to the CEO NON-GAAP FINANCIAL MEASURES.During this call,well use non-GAAP measures when talking about the companys financial performance and financial condition And you can find a reconciliation of these non-GAAP measures in this mornings press releas

6、e and in the reconciliation document posted to the Investor Relations portion of our website .J.David Joyner President,Chief Executive Officer&Director BUSINESS HIGHLIGHTS.Opening Remarks We are pleased to report another consecutive quarter of solid results as we execute against our ambition of beco

word格式文档无特别注明外均可编辑修改,预览文件经过压缩,下载原文更清晰!
三个皮匠报告文库所有资源均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
根据报告的内容,以下是全文主要内容的简明扼要概括: 1. CVS Health在2025年第二季度实现了强劲的业绩,调整后营业收入为380亿美元,调整后每股收益为1.81美元,均符合预期。 2. 公司提高了2025年全年调整后每股收益指引,从6.00-6.20美元上调至6.30-6.40美元,总收入指引至少为3915亿美元。 3. 医疗福利部门调整后营业利润预计为242亿美元,医疗保健交付部门因Oak Street医疗费用比率上升而面临压力,下调全年调整后营业利润指引200亿美元。 4. 药房与消费者健康部门调整后营业利润预计至少为568亿美元,得益于处方量和前店销量的增长。 5. 公司正在推进药房报销模式改革,计划在2026年将政府业务转移到基于成本的定价模式。 6. 公司承诺在未来10年投资2000亿美元支持医疗保健转型,以降低摩擦、提高透明度和加强医患合作。 7. 公司对2025年剩余时间的医疗费用趋势持谨慎态度,但整体业绩符合预期,正在朝着成为美国最值得信赖的医疗保健公司的目标迈进。
CVS Health第二季度业绩如何? Aetna业务有何进展? 药房业务表现如何?
客服
商务合作
小程序
服务号
折叠